Jose L Valderrabano, MD | |
208 Calle Tulipan, Urb. San Francisco, San Juan, PR 00927-6221 | |
(787) 763-2032 | |
(787) 281-6395 |
Full Name | Jose L Valderrabano |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 47 Years |
Location | 208 Calle Tulipan, San Juan, Puerto Rico |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083719124 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 6195 (Puerto Rico) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Centro Medico Del Turabo Inc | 9335051952 | 42 |
Dla Imaging Llc | 4981986015 | 18 |
Salud Integral En La Montana Inc | 8527972827 | 70 |
News Archive
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Also in the news, home health care aides are waiting for new labor rules which will determine whether they receive minimum wage.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Mayo Clinic will break ground for a cutting edge cancer therapy facility on December 13 at its hospital campus in Phoenix. Construction begins this month for a massive $182 million facility to house Mayo Clinic's Proton Beam Therapy program - marking a new era in cancer treatment.
› Verified 9 days ago
Entity Name | Med Centro Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295727147 PECOS PAC ID: 5890692131 Enrollment ID: O20031216000213 |
News Archive
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Also in the news, home health care aides are waiting for new labor rules which will determine whether they receive minimum wage.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Mayo Clinic will break ground for a cutting edge cancer therapy facility on December 13 at its hospital campus in Phoenix. Construction begins this month for a massive $182 million facility to house Mayo Clinic's Proton Beam Therapy program - marking a new era in cancer treatment.
› Verified 9 days ago
Entity Name | Salud Integral En La Montana Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275556946 PECOS PAC ID: 8527972827 Enrollment ID: O20040605000314 |
News Archive
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Also in the news, home health care aides are waiting for new labor rules which will determine whether they receive minimum wage.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Mayo Clinic will break ground for a cutting edge cancer therapy facility on December 13 at its hospital campus in Phoenix. Construction begins this month for a massive $182 million facility to house Mayo Clinic's Proton Beam Therapy program - marking a new era in cancer treatment.
› Verified 9 days ago
Entity Name | Salud Integral En La Montana Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1487677159 PECOS PAC ID: 8527972827 Enrollment ID: O20040721000677 |
News Archive
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Also in the news, home health care aides are waiting for new labor rules which will determine whether they receive minimum wage.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Mayo Clinic will break ground for a cutting edge cancer therapy facility on December 13 at its hospital campus in Phoenix. Construction begins this month for a massive $182 million facility to house Mayo Clinic's Proton Beam Therapy program - marking a new era in cancer treatment.
› Verified 9 days ago
Entity Name | Salud Integral En La Montana Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184647851 PECOS PAC ID: 8527972827 Enrollment ID: O20040729001210 |
News Archive
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Also in the news, home health care aides are waiting for new labor rules which will determine whether they receive minimum wage.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Mayo Clinic will break ground for a cutting edge cancer therapy facility on December 13 at its hospital campus in Phoenix. Construction begins this month for a massive $182 million facility to house Mayo Clinic's Proton Beam Therapy program - marking a new era in cancer treatment.
› Verified 9 days ago
Entity Name | Salud Integral En La Montana Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578586244 PECOS PAC ID: 8527972827 Enrollment ID: O20040803000311 |
News Archive
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Also in the news, home health care aides are waiting for new labor rules which will determine whether they receive minimum wage.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Mayo Clinic will break ground for a cutting edge cancer therapy facility on December 13 at its hospital campus in Phoenix. Construction begins this month for a massive $182 million facility to house Mayo Clinic's Proton Beam Therapy program - marking a new era in cancer treatment.
› Verified 9 days ago
Entity Name | Salud Integral En La Montana Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1316970833 PECOS PAC ID: 8527972827 Enrollment ID: O20040806000074 |
News Archive
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Also in the news, home health care aides are waiting for new labor rules which will determine whether they receive minimum wage.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Mayo Clinic will break ground for a cutting edge cancer therapy facility on December 13 at its hospital campus in Phoenix. Construction begins this month for a massive $182 million facility to house Mayo Clinic's Proton Beam Therapy program - marking a new era in cancer treatment.
› Verified 9 days ago
Entity Name | Caribe Physicians Plaza Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215051404 PECOS PAC ID: 0042246712 Enrollment ID: O20050713001119 |
News Archive
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Also in the news, home health care aides are waiting for new labor rules which will determine whether they receive minimum wage.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Mayo Clinic will break ground for a cutting edge cancer therapy facility on December 13 at its hospital campus in Phoenix. Construction begins this month for a massive $182 million facility to house Mayo Clinic's Proton Beam Therapy program - marking a new era in cancer treatment.
› Verified 9 days ago
Entity Name | Centro Medico Del Turabo Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710107883 PECOS PAC ID: 9335051952 Enrollment ID: O20080212000105 |
News Archive
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Also in the news, home health care aides are waiting for new labor rules which will determine whether they receive minimum wage.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Mayo Clinic will break ground for a cutting edge cancer therapy facility on December 13 at its hospital campus in Phoenix. Construction begins this month for a massive $182 million facility to house Mayo Clinic's Proton Beam Therapy program - marking a new era in cancer treatment.
› Verified 9 days ago
Entity Name | Mediko Imaging Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831205236 PECOS PAC ID: 8628042199 Enrollment ID: O20090102000483 |
News Archive
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Also in the news, home health care aides are waiting for new labor rules which will determine whether they receive minimum wage.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Mayo Clinic will break ground for a cutting edge cancer therapy facility on December 13 at its hospital campus in Phoenix. Construction begins this month for a massive $182 million facility to house Mayo Clinic's Proton Beam Therapy program - marking a new era in cancer treatment.
› Verified 9 days ago
Entity Name | Insight Management Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1891722989 PECOS PAC ID: 8527064062 Enrollment ID: O20100727000180 |
News Archive
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Also in the news, home health care aides are waiting for new labor rules which will determine whether they receive minimum wage.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Mayo Clinic will break ground for a cutting edge cancer therapy facility on December 13 at its hospital campus in Phoenix. Construction begins this month for a massive $182 million facility to house Mayo Clinic's Proton Beam Therapy program - marking a new era in cancer treatment.
› Verified 9 days ago
Entity Name | Aguada Medical Center Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598057374 PECOS PAC ID: 0840462727 Enrollment ID: O20111019000410 |
News Archive
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Also in the news, home health care aides are waiting for new labor rules which will determine whether they receive minimum wage.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Mayo Clinic will break ground for a cutting edge cancer therapy facility on December 13 at its hospital campus in Phoenix. Construction begins this month for a massive $182 million facility to house Mayo Clinic's Proton Beam Therapy program - marking a new era in cancer treatment.
› Verified 9 days ago
Entity Name | Salud Integral En La Montana Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1639372618 PECOS PAC ID: 8527972827 Enrollment ID: O20160122000568 |
News Archive
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Also in the news, home health care aides are waiting for new labor rules which will determine whether they receive minimum wage.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Mayo Clinic will break ground for a cutting edge cancer therapy facility on December 13 at its hospital campus in Phoenix. Construction begins this month for a massive $182 million facility to house Mayo Clinic's Proton Beam Therapy program - marking a new era in cancer treatment.
› Verified 9 days ago
Entity Name | Dla Imaging Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366890311 PECOS PAC ID: 4981986015 Enrollment ID: O20170124002548 |
News Archive
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Also in the news, home health care aides are waiting for new labor rules which will determine whether they receive minimum wage.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Mayo Clinic will break ground for a cutting edge cancer therapy facility on December 13 at its hospital campus in Phoenix. Construction begins this month for a massive $182 million facility to house Mayo Clinic's Proton Beam Therapy program - marking a new era in cancer treatment.
› Verified 9 days ago
Entity Name | Guaynabo Radiology, Llc |
---|---|
Entity Type | Part B Supplier - Hospital Department(s) |
Entity Identifiers | NPI Number: 1659858017 PECOS PAC ID: 4082956784 Enrollment ID: O20190429002938 |
News Archive
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Also in the news, home health care aides are waiting for new labor rules which will determine whether they receive minimum wage.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Mayo Clinic will break ground for a cutting edge cancer therapy facility on December 13 at its hospital campus in Phoenix. Construction begins this month for a massive $182 million facility to house Mayo Clinic's Proton Beam Therapy program - marking a new era in cancer treatment.
› Verified 9 days ago
Entity Name | Ecoimagenes De Puerto Rico, Corp. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548572555 PECOS PAC ID: 7012280761 Enrollment ID: O20210504000092 |
News Archive
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Also in the news, home health care aides are waiting for new labor rules which will determine whether they receive minimum wage.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Mayo Clinic will break ground for a cutting edge cancer therapy facility on December 13 at its hospital campus in Phoenix. Construction begins this month for a massive $182 million facility to house Mayo Clinic's Proton Beam Therapy program - marking a new era in cancer treatment.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Jose L Valderrabano, MD 208 Calle Tulipan, Urb. San Francisco, San Juan, PR 00927-6221 Ph: (787) 763-2032 | Jose L Valderrabano, MD 208 Calle Tulipan, Urb. San Francisco, San Juan, PR 00927-6221 Ph: (787) 763-2032 |
News Archive
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Also in the news, home health care aides are waiting for new labor rules which will determine whether they receive minimum wage.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Mayo Clinic will break ground for a cutting edge cancer therapy facility on December 13 at its hospital campus in Phoenix. Construction begins this month for a massive $182 million facility to house Mayo Clinic's Proton Beam Therapy program - marking a new era in cancer treatment.
› Verified 9 days ago
Bernardo Jose Marques Diaz, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 310 Lomas Verdes Ave. Suite 208, San Juan, PR 00927 Phone: 787-751-3150 Fax: 787-767-0338 | |
Dr. Roberto F Marchan, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 271 Ave J T Pinero, San Juan, PR 00927 Phone: 787-759-9660 Fax: 787-759-9660 | |
Wilmarie Rivera Hernandez, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 617 Calle Manuel Pavia, San Juan, PR 00909 Phone: 787-625-1446 | |
Dr. Wilma Rodriguez Mojica, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Fernandez Street No. 6 , Third Floor, San Juan, PR 00918 Phone: 787-763-6336 Fax: 787-763-6207 | |
Luis Garcia Paredes, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1462 Calle Prof Augusto Rodriguez, San Juan, PR 00909 Phone: 787-641-1616 | |
Mr. Roberto J Sein, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: Ave De Diego 201, Plaza San Fco Ofic #30, San Juan, PR 00927 Phone: 787-751-5587 Fax: 787-753-4631 | |
Dr. Ivonne Marquez Valencia, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 258 Calle San Jorge, San Juan, PR 00912 Phone: 787-727-1000 |